Latest News and Press Releases
Want to stay updated on the latest news?
-
-- First clinical authorization for an in vivo Prime Editing therapy from Prime Medicine -- -- PM577a targets the H1069Q mutation in the ATP7B gene, the most prevalent WD-causing allele in North...
-
SUNNYVALE, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
-
NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- RoboStrategy, Inc. (Nasdaq: BOT) (“RoboStrategy” or the “Fund”), a registered closed end fund providing exposure to private companies in robotics and...
-
Malibu, California, June 18, 2026 (GLOBE NEWSWIRE) -- Trio Petroleum Corp ("Trio" or the "Company") (NYSE American: TPET) is pleased to provide shareholders with an update regarding its acquisition...
-
Halberd Corporation Ships Latest NeuroSense AI Version, Advancing Voice-Based Behavioral Monitoring
-
SUMMIT, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a consumer products company, today announced that it has mailed proxy materials previously...
-
SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics...
-
VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial...
-
LOS ANGELES, June 18, 2026 (GLOBE NEWSWIRE) -- RemoteTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout technology companies, products...
-
Type A Meeting Scheduled with FDA to Potentially Clarify Path to GTx-104 NDA Resubmission Phase 3 STRIVE-ON Safety Trial Data Presented at Multiple Medical Conferences Company Continues...